{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:48:27Z","timestamp":1788382107639,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.lfs.2022.121110","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T23:43:25Z","timestamp":1666223005000},"page":"121110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet"],"prefix":"10.1016","volume":"310","author":[{"given":"Sai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Fang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2022.121110_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121110_bb0010","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.lfs.2022.121110_bb0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2022.121110_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.lfs.2022.121110_bb0025","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"10290","key":"10.1016\/j.lfs.2022.121110_bb0030","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lfs.2022.121110_bb0035","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41575-018-0089-3","article-title":"Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators","volume":"16","author":"Piccinin","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"437","key":"10.1016\/j.lfs.2022.121110_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9840","article-title":"Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target","volume":"10","author":"Liu","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.lfs.2022.121110_bb0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MOG.0000000000000528","article-title":"Current treatment options for nonalcoholic fatty liver disease","volume":"35","author":"Shetty","year":"2019","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121110_bb0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.lfs.2022.121110_bb0055","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","article-title":"Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?","volume":"158","author":"Aron-Wisnewsky","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.lfs.2022.121110_bb0060","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41467-019-09455-9","article-title":"A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease","volume":"10","author":"Caussy","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.lfs.2022.121110_bb0065","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1111\/jgh.15487","article-title":"Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease","volume":"36","author":"Iwaki","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2022.121110_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2017.04.021","article-title":"Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice","volume":"806","author":"Sun","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"24","key":"10.1016\/j.lfs.2022.121110_bb0075","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1080\/14786419.2020.1824223","article-title":"Hepatoprotective effect of total flavonoids from Glycyrrhiza uralensis Fisch in liver injury mice","volume":"35","author":"Gou","year":"2021","journal-title":"Nat. Prod. Res."},{"issue":"5","key":"10.1016\/j.lfs.2022.121110_bb0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/cells8050447","article-title":"Protective effects of licochalcone A ameliorates obesity and non-alcoholic fatty liver disease via promotion of the Sirt-1\/AMPK pathway in mice fed a high-fat diet","volume":"8","author":"Liou","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.lfs.2022.121110_bb0085","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/ptr.3728","article-title":"The efficacy of licorice root extract in decreasing transaminase activities in non-alcoholic fatty liver disease: a randomized controlled clinical trial","volume":"26","author":"Hajiaghamohammadi","year":"2012","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.lfs.2022.121110_bb0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4093\/dmj.2019.0042","article-title":"Combination of probiotics and Salvia miltiorrhiza polysaccharide alleviates hepatic steatosis via gut microbiota modulation and insulin resistance improvement in high fat-induced NAFLD mice","volume":"44","author":"Wang","year":"2020","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.lfs.2022.121110_bb0095","doi-asserted-by":"crossref","first-page":"3413186","DOI":"10.1155\/2020\/3413186","article-title":"Kangtaizhi granule alleviated nonalcoholic fatty liver disease in high-fat diet-fed rats and HepG2 cells via AMPK\/mTOR signaling pathway","volume":"2020","author":"Zhang","year":"2020","journal-title":"J. Immunol. Res."},{"issue":"9","key":"10.1016\/j.lfs.2022.121110_bb0100","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1021\/acs.molpharmaceut.8b00347","article-title":"Diammonium glycyrrhizinate protects against nonalcoholic fatty liver disease in mice through modulation of gut microbiota and restoration of intestinal barrier","volume":"15","author":"Li","year":"2018","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.lfs.2022.121110_bb0105","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1124\/dmd.118.082008","article-title":"Glycyrrhizin alleviates nonalcoholic steatohepatitis via modulating bile acids and meta-inflammation","volume":"46","author":"Yan","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2022.121110_bb0110","doi-asserted-by":"crossref","first-page":"2862173","DOI":"10.1155\/2016\/2862173","article-title":"The pathogenesis of nonalcoholic fatty liver disease: interplay between diet, gut microbiota, and genetic background","volume":"2016","author":"Yu","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"issue":"9","key":"10.1016\/j.lfs.2022.121110_bb0115","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.molmet.2016.06.003","article-title":"Non-alcoholic fatty liver and the gut microbiota","volume":"5","author":"Bashiardes","year":"2016","journal-title":"Mol. Metab."},{"issue":"3","key":"10.1016\/j.lfs.2022.121110_bb0120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/19490976.2019.1681861","article-title":"Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis","volume":"11","author":"Astbury","year":"2020","journal-title":"Gut Microbes"},{"issue":"19","key":"10.1016\/j.lfs.2022.121110_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900249","article-title":"Diet consisting of balanced yogurt, fruit, and vegetables modifies the gut microbiota and protects mice against nonalcoholic fatty liver disease","volume":"63","author":"Kong","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"issue":"6","key":"10.1016\/j.lfs.2022.121110_bb0130","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.aohep.2019.06.020","article-title":"Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis","volume":"18","author":"Liu","year":"2019","journal-title":"Ann. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121110_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40364-020-00239-8","article-title":"Dysregulated bile acid receptor-mediated signaling and IL-17A induction are implicated in diet-associated hepatic health and cognitive function","volume":"8","author":"Jena","year":"2020","journal-title":"Biomark Res."},{"issue":"11","key":"10.1016\/j.lfs.2022.121110_bb0140","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s00535-017-1331-4","article-title":"Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model","volume":"52","author":"Kishida","year":"2017","journal-title":"J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121110_bb0145","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"5","key":"10.1016\/j.lfs.2022.121110_bb0150","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.039206","article-title":"Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease","volume":"12","author":"Carbajo-Pescador","year":"2019","journal-title":"Dis. Model. Mech."},{"issue":"9","key":"10.1016\/j.lfs.2022.121110_bb0155","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/ismej.2015.11","article-title":"A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles, geography and ethnicities","volume":"9","author":"Zhang","year":"2015","journal-title":"ISME J."},{"issue":"3","key":"10.1016\/j.lfs.2022.121110_bb0160","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/19490976.2019.1681861","article-title":"Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis","volume":"11","author":"Astbury","year":"2020","journal-title":"Gut Microbes"},{"issue":"10","key":"10.1016\/j.lfs.2022.121110_bb0165","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00235-18","article-title":"Metabolism of oxo-bile acids and characterization of recombinant 12\u03b1-hydroxysteroid dehydrogenases from bile acid 7\u03b1-dehydroxylating human gut bacteria","volume":"84","author":"Doden","year":"2018","journal-title":"Appl. Environ. Microb."},{"issue":"3","key":"10.1016\/j.lfs.2022.121110_bb0170","doi-asserted-by":"crossref","first-page":"G227","DOI":"10.1152\/ajpgi.00267.2012","article-title":"A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids","volume":"304","author":"Stenman","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2022.121110_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.584090","article-title":"Da-Chai-Hu decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease through remodeling the gut microbiota and modulating the serum metabolism","volume":"11","author":"Cui","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2022.121110_bb0180","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jff.2017.06.030","article-title":"Dietary and lifestyle disease indices and caecal microbiota in high fat diet, dietary fibre free diet, or DSS induced IBD models in ICR mice","volume":"35","author":"Takashi","year":"2017","journal-title":"J. Funct. Foods"},{"issue":"4","key":"10.1016\/j.lfs.2022.121110_bb0185","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41385-019-0144-6","article-title":"Modulation of intestinal microbiota by glycyrrhizic acid prevents high-fat diet-enhanced pre-metastatic niche formation and metastasis","volume":"12","author":"Qiu","year":"2019","journal-title":"Mucosal Immunol."},{"issue":"11","key":"10.1016\/j.lfs.2022.121110_bb0190","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1039\/D1FO04260B","article-title":"Hawk tea prevents high-fat diet-induced obesity in mice by activating the AMPK\/ACC\/SREBP1c signaling pathways and regulating the gut microbiota","volume":"13","author":"Tao","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.lfs.2022.121110_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118457","article-title":"Liraglutide modulates gut microbiota and attenuates nonalcoholic fatty liver in db\/db mice","volume":"261","author":"Liu","year":"2020","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.lfs.2022.121110_bb0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2006.06.008","article-title":"Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis","volume":"4","author":"Uyeda","year":"2006","journal-title":"Cell Metab."},{"issue":"16","key":"10.1016\/j.lfs.2022.121110_bb0205","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1073\/pnas.161284298","article-title":"A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver","volume":"98","author":"Yamashita","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.lfs.2022.121110_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522008104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522008104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:06:34Z","timestamp":1762211194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522008104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":42,"alternative-id":["S0024320522008104"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121110","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"121110"}}